BIOL Biolase Inc

BIOLASE® to Host 2017 Second Quarter Financial Results Conference Call on August 7

IRVINE, Calif.--(BUSINESS WIRE)--

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, August 7, 2017, at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter and six months ended June 30, 2017, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.

Phone Participation

To listen to the conference call live via telephone, dial 877-407-4019 from the U.S. or, for international callers, dial 1-201-689-8337, approximately 10 minutes before the start time.

Webcast Participation

To listen to the conference call live via the Internet, visit the Investors section of the BIOLASE website at www.biolase.com.

Replay

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products incorporate approximately 210 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE’s innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 34,200 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase® iPlus™, Waterlase Express™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

BIOLASE® and Waterlase® are registered trademarks of BIOLASE, Inc.

EN
31/07/2017

Underlying

BIOLBiolase Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biolase Inc

Free Trial
BIOL BIOLASE INC

1 director bought

A director at Biolase Inc bought 25,000 shares at 1.671USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

08/18/18 August 18, 2018 1 EN
 PRESS RELEASE
Free
BIOL BIOLASE INC

BIOLASE Announces Expiration of Rights Offering

IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the subscription period for its previously announced rights offering to holders of shares of its common stock expired at 5:00 p.m., Eastern Time, on November 29, 2017, and these rights are no longer exercisable. The Company received basic subscriptions and over-subscriptions for a total of 26,307,719 shares, exceeding the 26,302,703 shares offered in the rights offering. Available shares will be distributed...

November 30, 2017 1 EN
 PRESS RELEASE
Free
BIOL BIOLASE INC

BIOLASE to Conduct Demos of Portable Waterlase Expressâ„¢ All-Tissue L...

IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it will be conducting demonstrations of its recently launched Waterlase Express all-tissue laser system at the Greater New York Dental Meeting next week at the Jacob K. Javits Convention Center. Dr. Samuel B. Low, the company’s chief dental officer, will also be presenting two continuing education workshops at the conference. The sessions will address how dentists can properly incorporate lasers into their practice ...

November 22, 2017 1 EN
 PRESS RELEASE
Free
BIOL BIOLASE INC

BIOLASE to Present at the Singular Research Best of the Uncovered 12th...

IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it is scheduled to present at the Singular Research Best of the Uncovered 12th Annual Conference 2017 on Monday, December 4, 2017, at 3:00 PM Pacific Time. BIOLASE President and Chief Executive Officer Harold C. Flynn, Jr. will be giving the presentation and meeting with investors. The conference is being held at the Hotel Angeleno, 170 North Church Lane, Los Angeles, CA 90049. A live webcast and 90-day rep...

November 16, 2017 1 EN
 PRESS RELEASE
Free
BIOL BIOLASE INC

BIOLASE Announces Commencement of Rights Offering

IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has commenced its previously announced rights offering to holders of shares of its common stock. Under the terms of the rights offering, the Company distributed to its shareholders as of 5:00 p.m., Eastern Time, on November 8, 2017, the record date, 0.346 subscription rights exercisable for each share of the Company’s common stock owned. Each whole subscription right entitles the holder to purchase one s...

November 9, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch